All Stories

  1. An update on adverse drug reactions related to β-lactam antibiotics

    Article • Expert Opinion on Drug Safety, April 2018, Taylor & Francis

    Dr Konstantinos Vardakas

  2. Colistin loading dose: evaluation of the published pharmacokinetic and clinical data

    Article • International Journal of Antimicrobial Agents, November 2016, Elsevier

    Dr Konstantinos Vardakas

  3. Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis

    Article • International Journal of Antimicrobial Agents, September 2016, Elsevier

    Dr Konstantinos Vardakas

  4. The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?

    Article • Expert Review of Anti-infective Therapy, July 2016, Taylor & Francis

    Dr Konstantinos Vardakas

  5. Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study

    Article • Archives of Virology, July 2016, Springer Science + Business Media

    Dr Konstantinos Vardakas

  6. Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis

    Article • International Journal of Antimicrobial Agents, July 2016, Elsevier

    Dr Konstantinos Vardakas

  7. Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature

    Article • International Journal of Antimicrobial Agents, April 2016, Elsevier

    Dr Konstantinos Vardakas

  8. Fosfomycin

    Article • Clinical Microbiology Reviews, March 2016, ASM Journals

    Dr Konstantinos Vardakas

  9. Trimethoprim/sulfamethoxazole for Acinetobacter spp.: A review of current microbiological and clinical evidence

    Article • International Journal of Antimicrobial Agents, September 2015, Elsevier

    Dr Konstantinos Vardakas

  10. An analysis of factors contributing to PubMed's growth

    Article • Journal of Informetrics, July 2015, Elsevier

    Dr Konstantinos Vardakas

  11. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit

    Article • Journal of Infection, June 2015, Elsevier

    Dr Konstantinos Vardakas

  12. Tigecycline for carbapenem-resistant Klebsiellapneumoniaeinfections in the intensive care unit

    Article • Infectious Diseases, May 2015, Taylor & Francis

    Dr Konstantinos Vardakas

  13. Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis

    Article • Journal of Neurosurgery, May 2015, Journal of Neurosurgery Publishing Group (JNSPG)

    Athanasios Konstantelias, Dr Konstantinos Vardakas

  14. Tetracyclines for multidrug-resistant Acinetobacter baumannii infections

    Article • International Journal of Antimicrobial Agents, May 2015, Elsevier

    Dr Konstantinos Vardakas

  15. Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review

    Article • International Journal of Antimicrobial Agents, March 2015, Elsevier

    Dr Konstantinos Vardakas

  16. Antistaphylococcal penicillins versus cephalosporins for definitive treatment of meticillin-susceptible Staphylococcus aureus bacteraemia: A systematic review and meta-analysis

    Article • International Journal of Antimicrobial Agents, December 2014, Elsevier

    Dr Konstantinos Vardakas

  17. Vacuum-Assisted Closure versus Closure without Vacuum Assistance for Preventing Surgical Site Infections and Infections of Chronic Wounds: A Meta-Analysis of Randomized Controlled Trials

    Article • Surgical Infections, August 2014, Mary Ann Liebert Inc

    Dr Konstantinos Vardakas

  18. Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections

    Article • Emerging Infectious Diseases, July 2014, Centers for Disease Control and Prevention (CDC)

    Dr Konstantinos Vardakas

  19. Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections

    Article • International Journal of Antimicrobial Agents, July 2014, Elsevier

    Dr Konstantinos Vardakas

  20. Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections

    Article • Clinical Investigation, January 2014, Future Science

    Dr Konstantinos Vardakas

  21. Extended or continuous versus short-term intravenous infusion of cephalosporins: a meta-analysis

    Article • Expert Review of Anti-infective Therapy, June 2013, Informa Healthcare

    Dr Konstantinos Vardakas

  22. Impact of Vacuum-Assisted Closure (VAC) Therapy on Clinical Outcomes of Patients with Sternal Wound Infections: A Meta-Analysis of Non-Randomized Studies

    Article • PLoS ONE, May 2013, PLOS

    Dr Konstantinos Vardakas

  23. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: The study, the patient, the bug or the drug?

    Article • Journal of Infection, May 2013, Elsevier

    Athanasios Konstantelias, Dr Konstantinos Vardakas

  24. A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies

    Article • Supportive Care in Cancer, April 2013, Springer Science + Business Media

    Dr Konstantinos Vardakas

  25. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: A meta-analysis

    Article • International Journal of Antimicrobial Agents, April 2013, Elsevier

    Dr Konstantinos Vardakas

  26. Understanding of Statistical Terms Routinely Used in Meta-Analyses: An International Survey among Researchers

    Article • PLoS ONE, January 2013, PLOS

    Dr Konstantinos Vardakas

  27. Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review

    Article • Expert Review of Anti-infective Therapy, January 2013, Informa Healthcare

    Dr Konstantinos Vardakas

  28. Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression

    Article • International Journal of Antimicrobial Agents, December 2012, Elsevier

    Dr Konstantinos Vardakas

  29. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis

    Article • International Journal of Infectious Diseases, November 2012, Elsevier

    Athanasios Konstantelias, Dr Konstantinos Vardakas

  30. Efficacy and Safety of Telavancin in Clinical Trials: A Systematic Review and Meta-Analysis

    Article • PLoS ONE, August 2012, PLOS

    Dr Konstantinos Vardakas

  31. Ventilator-associated sinusitis in adults: Systematic review and meta-analysis

    Article • Respiratory Medicine, August 2012, Elsevier

    Dr Konstantinos Vardakas

  32. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence

    Article • International Journal of Antimicrobial Agents, July 2012, Elsevier

    Dr Konstantinos Vardakas

  33. Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design

    Article • Mayo Clinic Proceedings, April 2012, Elsevier

    Dr Konstantinos Vardakas

  34. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review

    Article • International Journal of Infectious Diseases, November 2010, Elsevier

    Dr Konstantinos Vardakas

  35. PREDICTORS OF MORTALITY IN ADULT PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA

    Article • Shock, June 2010, Wolters Kluwer Health

    Dr Konstantinos Vardakas

  36. Study conclusions should reflect results

    Article • Canadian Medical Association Journal, March 2009, Canadian Medical Association (CMA)

    Dr Konstantinos Vardakas

  37. Association of Pharmacokinetic and Pharmacodynamic Aspects of Linezolid with Infection Outcome

    Article • Current Drug Metabolism, January 2009, Bentham Science Publishers

    Dr Konstantinos Vardakas

  38. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials

    Article • The Lancet Infectious Diseases, September 2008, Elsevier

    Dr Konstantinos Vardakas

  39. Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials

    Article • Diabetes Research and Clinical Practice, June 2008, Elsevier

    Dr Konstantinos Vardakas

  40. Sex differences in the incidence and severity of respiratory tract infections

    Article • Respiratory Medicine, April 2008, Elsevier

    Dr Konstantinos Vardakas

  41. Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections

    Article • Drug Safety, January 2008, Springer Science + Business Media

    Dr Konstantinos Vardakas

  42. Decreasing the incidence and impact of infections in neutropenic patients: evidence from meta-analyses of randomized controlled trials

    Article • Current Medical Research and Opinion, January 2008, Informa Healthcare

    Dr Konstantinos Vardakas

  43. Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

    Article • The Lancet Infectious Diseases, January 2008, Elsevier

    Dr Konstantinos Vardakas

  44. Impact of passive humidification on clinical outcomes of mechanically ventilated patients: A meta-analysis of randomized controlled trials*

    Article • Critical Care Medicine, December 2007, Wolters Kluwer Health

    Dr Konstantinos Vardakas

  45. Decreasing the incidence and impact of infections in neutropenic patients: evidence from meta-analyses of randomized controlled trials

    Article • Current Medical Research and Opinion, November 2007, Informa Healthcare

    Dr Konstantinos Vardakas

  46. Interpretation of the Findings of a Cohort Study of Bacteremic Patients With Community-Acquired Pneumonia

    Article • CHEST Journal, November 2007, Elsevier

    Dr Konstantinos Vardakas

  47. Linezolid: effectiveness and safety for approved and off-label indications

    Article • Expert Opinion on Pharmacotherapy, October 2007, Informa Healthcare

    Dr Konstantinos Vardakas

  48. Sex differences in the incidence and severity of respiratory tract infections

    Article • Respiratory Medicine, September 2007, Elsevier

    Dr Konstantinos Vardakas

  49. Linezolid for the treatment of adults with bone and joint infections

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Dr Konstantinos Vardakas

  50. Intravenous heparin in combination with antibiotics for the treatment of deep vein septic thrombophlebitis: A systematic review

    Article • European Journal of Pharmacology, February 2007, Elsevier

    Dr STAVROS ATHANASIOU, Dr Konstantinos Vardakas

  51. Infectious complications of monoclonal antibodies used in cancer therapy

    Article • Cancer, January 2007, Wiley

    Dr Konstantinos Vardakas

  52. Fluoroquinolones vs β-Lactams for Empirical Treatment of Immunocompetent Patients With Skin and Soft Tissue Infections: A Meta-analysis of Randomized Controlled Trials

    Article • Mayo Clinic Proceedings, December 2006, Elsevier

    Dr Konstantinos Vardakas

  53. Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients

    Article • Clinical Microbiology and Infection, July 2006, Elsevier

    Dr Konstantinos Vardakas

  54. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials*

    Article • Critical Care Medicine, April 2006, Wolters Kluwer Health

    Dr Konstantinos Vardakas

  55. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy - response to Prentice et al

    Article • British Journal of Haematology, March 2006, Wiley

    Dr Konstantinos Vardakas

  56. Liposomal amphotericin B as antifungal prophylaxis in bone marrow transplant patients

    Article • American Journal of Hematology, January 2006, Wiley

    Dr Konstantinos Vardakas

  57. Outcome of Critically Ill Oldest-Old Patients (Aged 90 and Older) Admitted to the Intensive Care Unit

    Article • Journal of the American Geriatrics Society, January 2006, Wiley

    Dr Konstantinos Vardakas

  58. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials

    Article • British Journal of Haematology, October 2005, Wiley

    Dr Konstantinos Vardakas

  59. Effect of Aminoglycoside and β‐Lactam Combination Therapy versus β‐Lactam Monotherapy on the Emergence of Antimicrobial Resistance: A Meta‐analysis of Randomized, Controlled Trials

    Article • Clinical Infectious Diseases, July 2005, Oxford University Press (OUP)

    Dr Konstantinos Vardakas

  60. Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials

    Article • The Lancet Infectious Diseases, July 2005, Elsevier

    Dr Konstantinos Vardakas

  61. Meta-analysis of Vancomycin for the Treatment of Patients

    Article • SciVee, Inc

    Dr Konstantinos Vardakas